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Objective: To evaluate the performance of the newest version of 
the Pediatric Index of Mortality 3 score and compare it with the 
Pediatric Index of Mortality 2 in a multicenter national cohort of 
children admitted to PICU.
Design: Retrospective, prospective cohort study.
Setting: Seventeen Italian PICUs.
Patients: All children 0 to 15 years old admitted in PICU from 
January 2010 to October 2014.
Interventions: None.
Measurement and Main Results: Eleven thousand one hundred 
nine children were enrolled in the study. The mean Pediatric 
Index of Mortality 2 and 3 values of 4.9 and 3.9, respectively, 
differed significantly (p < 0.05). Overall mortality rate was 
3.9%, and the standardized mortality ratio was 0.80 for Pediat-
ric Index of Mortality 2 and 0.98 for Pediatric Index of Mortality 
3 (p < 0.05). The area under the curve of the receiver operating 
characteristic curves was similar for Pediatric Index of Mortality 
2 and Pediatric Index of Mortality 3. The Hosmer-Lemeshow 
test was not significant for Pediatric Index of Mortality 3 (p = 
0.21) but was highly significant for Pediatric Index of Mortality 
2 (p < 0.001), which overestimated death mainly in high-risk 
categories.
Conclusions: Mortality indices require validation in each country 
where it is used. The new Pediatric Index of Mortality 3 score per-
formed well in an Italian population. Both calibration and discrimi-
nation were appropriate, and the score more accurately predicted 
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To assure the effective use of PICU resources, mortality prediction models are necessary to adjust for case mix variation and severity of illness by assessing the standard-
ized mortality ratio (SMR). It is extremely important that risk 
of mortality indices is updated with predictors, coefficients, and 
models that are constantly recalibrated (1). The Pediatric Index 
of Mortality (PIM) is the only available score for the pediatric 
age group, which has been recently updated. The third edition 
(PIM 3) was published (2) in 2013, and it aimed to avoid a drift 
in calibration observed in previous data from two large national 
registries: the Paediatric Intensive Care Audit Network in the 
United Kingdom and the Ireland, Australian and New Zealand 
Paediatric Intensive Care registry (3, 4). Both reported an over-
prediction risk of mortality with poor performance in low-risk 
patients. In Italy, the previous version of PIM (5) was validated 
by a multicenter national study and showed good calibration 
and discrimination (6), but the observed mortality rate was 
lower than predicted. As suggested by the authors of the PIM 
score, new models should be validated in different settings and 
different populations to improve its general acceptance. The aim 
of this study was to evaluate the performance of the new risk of 
mortality model (PIM 3) and to compare it with the PIM 2 in an 
Italian PICU setting.
MATERIALS AND METHODS
Following the experience of other national registries (7–9), an 
Italian permanent registry for all PICU admissions was estab-
lished in 2010 (http://www.tipnet.cineca.it). All Italian medi-
cal/surgical PICUs were invited to participate in Network delle 
Terapie Intensive Pediatriche (TIPNet). From 2010 to 2014, the 
number of units participating in the registry increased from 13 
to 17 of 23 PICUs (56.5% and 73.9%, respectively ) distributed 
throughout the country. Data collected included gender, age, 
reason for admission, Pediatric Overall Performance Category 
scale (10), comorbidities, type of admission, source of admis-
sion, risk of mortality on admission, PICU length of stay, and 
outcome. The PIM 2 was used from January 2010 to December 
2013 and both PIM 2 and 3 from January to October 2014. The 
registry has been changed as needed to estimate the risk of death 
for both versions of the score. Furthermore, after assessing data 
consistency in the registry for the variables of interest for the 
years 2010–2013, the PIM 3 was retrospectively calculated apply-
ing the new risk diagnosis classification and the new coefficient 
for each variable. To verify appropriate data collection, the intra-
class correlation coefficient was calculated among centers.
All consecutive admissions from January 2010 to October 
2014 of children less than 16 years were considered for the 
study. Premature infants less than 36 weeks of gestational age 
were excluded from the analysis. Patients were excluded from 
the analysis if the data entry was incomplete.
STATISTICAL ANALYSIS
A descriptive analysis was made for the overall cohort and for 
each study year to verify homogeneity over time. Performance 
was validated by the SMR, which is the ratio of observed to 
expected (PIM predicted) deaths in a population with 95% 
CIs. CIs were estimated with the Byar approximation (11). 
Expected number of deaths was calculated as the average of 
overall predicted mortality times the number of patients in 
the population. Overall prediction of observed mortality was 
considered accurate when the SMR for the entire population 
was not significantly below or above 1. PIM 3 performance was 
tested with discrimination and calibration analysis and com-
pared with PIM 2. Discrimination was assessed through the 
area under the receiver operating characteristic (ROC) curve 
(AUC) (12). Calibration was assessed by the Hosmer-Lemeshow 
(HL) goodness-of-fit test for deciles of risk (13). For analysis, 
patients were divided into age groups (newborn, infant, pre-
school, school, and adolescent), deciles of risk of death, study 
years, patient types (medical, surgical, and trauma), main rea-
son of admission. Comparisons between PIM 2 and PIM 3 
were made with the Mann-Whitney U test for comparing the 
risk of death and through the SMRs and AUC ROC analysis 
in the different groups of patients. We did sensitivity analyses, 
testing the PIM scores in a restricted dataset. A subpopulation 
of the overall cohort was selected by identifying and exclud-
ing two specific groups of children with a possible bias in the 
PIM determination: medical elective admissions from home 
and children transferred from another ICU. Finally, observed 
and expected deaths for each unit were plotted to identify units 
with unexpectedly low or high mortality.
Statistical analysis and data management were performed 
with Excel (Excel 2010; Microsoft, Redmond, WA), R (R Project 
for Statistical Computing version 3.1.3, Vienna, Austria) and 
NCSS (NCSS 9.0, NCSS, LLC, Kaysville, UT). Results were con-
sidered significant at p value of less than 0.05.
Children’s Hospital Vittore Buzzi was the coordinator of the 
registry. The Ethical Committee performed the primary review 
and approved the study. Subsequently, each center participating 
in the registry received the approval from its ethical committee.
RESULTS
Of the 14,261 admissions in the registry at the time of the analysis, 
1,098 (7.7%) were excluded because of incomplete data, whereas 
2,054 (14.4%) were excluded due to age limits (Fig. 1). Therefore, 
11,109 admissions (77.9%) were considered for the study.
The characteristics of children admitted were homoge-
neous among the four study years (Table 1). The majority of 
children were Caucasian (84.3%). Nine hundred eight children 
were admitted more than once (number of admissions range, 
1–14) accounting for 1,629 admissions: 763 (46.8%) were 
planned admissions, 866 (53.2%) were unplanned. Ten admis-
sions were unplanned within 48 hours from PICU discharge. 
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Overall mortality was 3.9%, and mortality rate decreased from 
5.4% in 2010 to 3.8% in 2014.
To calculate the PIM 3 score, 1,047 children were recoded 
following the new score rules. Six hundred forty-nine children 
(5.8%) with seizures were reallocated to the low-risk diagnosis 
group. Three hundred eighty-nine children (3.5%) who had 
a high-risk diagnoses in the PIM 2 score were recoded as very 
high risk for the PIM 3. The intraclass correlation coefficient 
was 0.974 (95% CI, 0.93–0.995) for both PIM 2 and 3, suggest-
ing good agreement among raters.
PIM 3 Performance
The overall SMR was 0.98 (95% CI, 0.89–1.08). The AUC of the 
ROC curve for the entire cohort was 0.88 (95% CI, 0.86–0.89) 
(Fig. 2A). Calibration described by the HL test through stratifi-
cations for deciles of risk was not significant (p = 0.21) (Table 2). 
Analysis in each strata showed a nonsignificant difference except 
in the lowest risk group, where observed deaths were signifi-
cantly higher than expected (4 vs 1.25; p < 0.05). We removed 
planned admissions from home (n = 301) and those children 
admitted from another ICU (n = 586). Remaining 10,222 chil-
dren showed an SMR of 1.01. Both tests were then applied in the 
selected population with an equal discrimination (AUC = 0.88) 
but a significant HL test (p = 0.03) (Table 2).
Comparison of PIM 2 Versus PIM 3
The mean PIM 2 risk of death was always significantly higher 
than the mean PIM 3 for the entire cohort (4.9 vs 3.9; p < 0.05) 
and in all subgroups analyzed with the exception of the trauma 
and adolescent groups and of 2010 and 2011 cohorts.
The overall SMR was 0.80 with PIM 2 score and 0.98 with 
PIM 3 score (p < 0.05). Discrimination estimated through the 
AUC for PIM 2 was 0.88 (95% CI, 0.86–0.89) not significantly 
different from the PIM 3 value (p = 0.36) (Fig. 2B). The HL test 
was statistically significant for PIM 2 score (p < 0.05) (Table 2). 
Overprediction of deaths was observed in the highest risk deciles 
Figure 1. Flow chart of the study population.
TAbLE 1. Characteristics of the Study 
Population
Variable n = 11,109
Gender (women/men) 0.75
Study year
 2010 1,246 (11.2)
 2011 2,638 (23.7)
 2012 3,034 (27.3)
 2013 2,270 (20.4)
 2014 1,921 (17.3)
Age (mo)
 Mean (± sd) 46.3 (± 54.8)
 Median (IQR) 20.6 (3.7–73.3)
Class of age
 Newborn (0–7 d) 873 (7.9)
 Infant (0–12 mo) 3,758 (33.8)
 Preschool (1–6 yr) 3,690 (33.2)
 School (6–12 yr) 2,030 (18.3)
 Adolescent (12–16 yr) 758 (6.8)
Chronic complex conditiona 4,494 (43.9)
Admission unplanneda 6,160 (60.2)
Type of admission
 Medical 6,070 (54.6)
 Surgical 4,459 (40.1)
 Trauma 580 (5.2)
Length of stay
 Mean (± sd) 6.1 (± 15.5)
 Median (IQR) 2 (1–6)
Mortality 432 (3.9)
PIM2
 Mean (± sd) 4.9 (± 11.9)
 Median (IQR) 1.14 (0.4–3.8)
 Expected mortality (E) 540.4
 SMR (O/E) 0.80
PIM3
 Mean (± sd) 3.9 (± 10.8)
 Median (IQR) 1.03 (0.3–3.2)
 Expected mortality (E) 439.9
 SMR (O/E) 0.98
IQR = interquartile range, PIM = Pediatric Index of Mortality, E = expected, 
SMR = standardized mortality ratio, O = observed.
a Rate estimated over 10,237 children (newborn excluded).
Data are expressed as n (%) for discrete variable or otherwise indicated. 
Expected mortality has been calculated as the sum of all the PIM score.
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of PIM 2. PIM 3 performed better in most of the deciles except 
in the lowest risk group with an HL test that was not significant.
Expected versus observed deaths were plotted for each PICU 
using the two versions of the score. With the PIM 2, seven units 
had the observed mortality higher than the expected (SMR > 1) 
(Fig. 2C), whereas with the PIM 3, nine units had an observed 
mortality higher than the expected (Fig. 2D). Nevertheless, 
SMRs calculated using PIM 3 are closer to 1 (graphically shown 
by the dotted reference line) than using PIM 2.
Subgroup Performance
Calibration and discrimination were then assessed in all the sub-
groups. The numbers of expected deaths estimated by PIM 3 were 
not significantly different from those observed, whereas expected 
deaths predicted by PIM 2 were greater. PIM 3 performed bet-
ter than PIM 2 in most of the categories considered apart from 
adolescents where the SMR was 1.4 versus 1.2, respiratory (1.15 
vs 0.91) and cardiac surgical (1.2 vs 0.69). The AUC of the ROC 
curves was similar for both the scores and always greater than or 
equal to 0.80 in all groups (AUC range, 0.80–0.93).
DISCUSSION
Mortality scores are developed in specific populations with 
varying characteristics of case-mix, available resources, and 
treatment protocols, which may be different in other national 
settings. It is therefore important to have an external validation 
Figure 2. Comparison between Pediatric Index of Mortality (PIM) 2 and PIM3. A and b, Receiver operating characteristic curves. C and D, Predicted 
or observed deaths for each center. A and b, Dotted line is the reference line. C and D, Continuous line is the reference line for equal observed and 
expected deaths (standardized mortality ratio [SMR] = 1). AUC = area under the curve.
Copyright © 2016 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Unauthorized reproduction of this article is prohibited
Quality and Safety
Pediatric Critical Care Medicine www.pccmjournal.org 255
to assess the model in each country using it. This study repre-
sents the first assessment of the new version (PIM 3) published 
in 2013 (5) in a different setting than the one in which it was 
developed.
Our results showed that using PIM 3, the SMR for the entire 
population was 0.98. The score performed very well in discrim-
ination and in calibration in our population. Discrimination 
was good with an acceptable AUC for the entire cohort. The 
observed value of 0.88 is the same as described by the origi-
nal article. Furthermore, discrimination was good among each 
subgroup analyzed. Classification for year of study, age, and 
admission diagnosis revealed an AUC always higher than 0.80. 
Calibration along deciles of risk through the HL test was not 
significant. Besides the statistical importance of this result, as 
clearly explained by Shann (14), the HL test should be evalu-
ated in depth in each of the 10 rows. Seven of 10 strata had an 
SMR higher than one, but most had a small difference between 
observed and expected deaths and above all without clinical 
meaning. The major difference was observed in the lowest risk 
of death decile. All four deaths recorded were children with 
chronic complex conditions (chronic renal failure, postanoxic 
cerebral palsy, epilepsy, and congenital malformation). Two of 
these children had severe disability on PICU admission, and 
life-sustaining therapies were withdrawn in agreement with 
the parents due to the poor quality of life expectancy. Both 
these patients did not have a high or a very high-risk diagnosis 
and account for a low risk of mortality score when compared 
with their general condition.
The new score was developed to improve mortality pre-
diction when compared with PIM 2, which had a tendency 
to over predict deaths. PIM 3 appears to perform better than 
PIM 2. Its SMR was significantly more appropriate than PIM 
2 with almost 100 less predicted deaths. In the previous study 
conducted in Italy to validate the PIM score, overprediction of 
death had been observed for PIM 2 (6).
Although the PIM score is a general mortality score, a criti-
cism may arise for the prediction risk of death among new-
borns. Indeed, in this group, both the PIM 2 and 3 versions 
overpredicted deaths with a poor SMR. A possible reason is the 
risk of death associated with given systolic blood pressure. As 
already discussed by Marcin and Wetzel (15), the PIM score has 
a possible limitation in the “one-size-fits-all” objective. Indeed, 
the ideal systolic blood pressure associated with the lowest risk 
of death is 120 mm Hg, and all the pressures lower than this 
value increase the risk of death. It is obvious that newborns, 
who have a physiologically lower pressure, would have a spuri-
ous PIM score.
The choice to exclude children with planned admission from 
home and children admitted from another ICU was justified by 
possible confounding factors in these two categories. The first 
group has a low potential risk of dying because they come into 
the hospital to set or adjust long-term home mechanical ven-
tilation. The second group includes children who had arrived 
from another ICU and who had already received intensive care 
treatment. Therefore, we believe that the score does not accu-
rately reflect the primary patient condition. Admission from 
another common ward is a different matter. Most of the time, 
these patients are not yet stabilized, either for respiratory or for 
cardiovascular problems, and are transferred due to the inabil-
ity of the hospital of origin to treat critically ill children. The 
removal of these patients changed slightly the score validation, 
for SMR, calibration, and discrimination.
To date, there are no other published studies that have exam-
ined PIM 3 performance. The strength of this study is that we 
analyzed a cohort of more than 10,000 children admitted to 17 
different PICUs. To date, only a few external validation studies 
TAbLE 2. Hosmer-Lemeshow Test for Deciles of Risk
PIM2 Overall Cohort PIM3 Overall Cohort PIM3 Selected Cohort
Values n O E Values n O E Values n O E
0.0002–0.0017 1,314 0 1.46 0.0001–0.0018 1,231 4 1.25 0.0001–0.0017 1,073 4 0.99
0.0017–0.0032 921 1 2.15 0.0018–0.0025 1,047 1 2.09 0.0017–0.0023 1,029 0 1.96
0.0032–0.0057 1,112 8 4.86 0.0025–0.0043 1,074 3 3.62 0.0023–0.0042 988 3 3.04
0.0057–0.0084 1,134 8 7.97 0.0043–0.0064 1,112 8 5.73 0.0042–0.0058 1,038 8 5.01
0.0084–0.0115 1,079 11 10.69 0.0064–0.0104 1,095 11 8.89 0.0058–0.0095 985 7 7.34
0.0115–0.0171 1,111 15 15.59 0.0104–0.0151 1,168 16 15.14 0.0095–0.0142 1,025 19 12.42
0.0171–0.0283 1,111 24 24.72 0.0151–0.0243 1,052 23 20.20 0.0142–0.0221 1,022 20 17.74
0.0283–0.0495 1,111 30 42.43 0.0243–0.0409 1,115 38 36.26 0.0221–0.0389 1,044 33 31.91
0.0495–0.1023 1,106 70 77.35 0.0409–0.0801 1,105 63 61.36 0.0389–0.0756 996 52 52.69
0.1023–0.9981 1,110 265 353.33 0.0801–0.9985 1,110 265 285.62 0.0756–0.9985 1,022 240 249.57
11,109 432 540.55 11,109 432 440.16 10,222 386 382.67
p < 0.001 p = 0.21 p = 0.03
PIM = Pediatric Index of Mortality, O = observed deaths, E = expected deaths.
Deciles of risk were derived by the Hosmer-Lemeshow function of R statistical software. Pediatric Index of Mortality values are reported as decimal.
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in pediatric intensive care have been performed with a suf-
ficiently large sample size (6, 16–19). As discussed by Shann 
(20), a severity score should not be validated in a single unit 
or in a too small population because of possible inappropriate 
statistical results.
Our study has two major limitations. The first is that most 
of the analysis (from 2010 to 2013) has been undertaken in a 
retrospective manner. However, PIM 3 maintained most vari-
ables from the previous version. The major changes were those 
regarding the coefficient of each variable and the classification 
of the risk diagnosis. Our registry was developed with the aim 
to collect data for research purposes, and all the information 
required to calculate PIM scores had been stored. Nevertheless 
possible inaccuracy, mainly for new admission diagnoses such 
as necrotizing enterocolitis and seizures, might be possible 
(underestimation). The second limitation is that data were 
collected over 5 years, and outcomes might change over time. 
These changes should be detected by the score; indeed, mortal-
ity rate decreased from 2010 to 2014 and the score performed 
better in the more recent study years (2013–2014) than in the 
previous 3 years.
CONCLUSIONS
PIM 3 is an easy to use and valid instrument to assess mor-
tality risk in a PICU population. Due to local differences in 
national health services that might influence performance, 
some authors have suggested that local adjustment of the 
coefficients used in severity of illness scores might enhance 
local performance. The use of local coefficients would, how-
ever, make comparison among PICUs in different countries 
problematic. In contrast to this, our results demonstrate 
that the standard PIM 3 score performed well in our Italian 
population. This is consistent with the use of a reliable inter-
national model for comparison among ICU populations in 
many countries.
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